Correction to: A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg

Ítems similars

• Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
  per: Palacios, S., et al.
  Publicat: (2020)
• A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg
  per: Palacios, Santiago, et al.
  Publicat: (2019)
• Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
  per: Palacios, Santiago, et al.
  Publicat: (2019)
• Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
  per: Palacios, Santiago, et al.
  Publicat: (2020)
• A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers
  per: Melka, Dace, et al.
  Publicat: (2020)